Nanoparticle-Based Combination Therapy for Resistant Melanoma
Source: AZO NANO, May 2025
A recent study published in Small addresses the persistent difficulty of treating refractory melanoma, an aggressive form of skin cancer that often does not respond to existing therapies.
Although diagnostic tools and immunotherapies have improved in recent years, a substantial number of patients remain unresponsive to current treatment options, highlighting the need for alternative therapeutic approaches.
The researchers in this study explore a strategy that combines intracellular stress targeting with immune modulation.